Related Articles
Anti-HuC and -HuD autoantibodies are differential sero-diagnostic markers for small cell carcinoma from large cell neuroendocrine carcinoma of the lung
Amrubicin monotherapy may be an effective second-line treatment for patients with large-cell neuroendocrine carcinoma or high-grade non-small-cell neuroendocrine carcinoma
Large cell neuroendocrine carcinoma of the lung that responded to nivolumab: A case report
Downregulation of drs tumor suppressor gene in highly malignant human pulmonary neuroendocrine tumors
Efficacy of immune checkpoint inhibitors in advanced large cell neuroendocrine carcinoma of the lung: A single‑institution experience